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California undoubtedly has become the nation’s
laboratory for the managed care experiment, which
seeks to transform how health care is financed. The
center of development of health maintenance orga-
nizations (HMOs) has been southern California,
dating back to their introduction by Kaiser-
Permanente in the 1930s. Although the list of criti-
cisms of our health care system is long, its principal
fault is financial cost. Spending 14% of the gross
domestic product on health care will eventually crip-
ple private enterprise and the public welfare.
Both business and government have embraced
the HMO concept as the salvation of a health care
system plagued by out-of-control expenditures.
However, the medical journals and economists that
praised this “new paradigm” for health financing
reform as anodyne1 now view it as anathema. Costs
are once again on the rise, and patients’ satisfaction
with their health care insurance declines.2,3 This
apostasy comes as no surprise to the physicians and
hospitals who toil under the micromanagement
engendered by diagnosis-related groups (DRGs)
and Resource-based Relative Value System—two
highly touted reforms that failed to stem the tide of
rising costs. The effects of HMOs, the government’s
latest incursion into vascular surgery practice, are the
subject of this report.
THE NEW HEALTH CARE GAME
Dr. Jerome Kassirer, editor of the New England
Journal of Medicine chose California’s for-profit
HMOs for an editorial diatribe that summarized
their avaricious business objectives—expand your
company, maximize the number of insured people
(“lives”), charge less than your competitors, and
make a nice profit.4 In 1980, 85 of California’s
HMO plans were not for profit and more than 90%
of HMO patients were enrolled in these plans.
Kaiser-Permanente dominated this market and sup-
ported it with an extensive hospital and clinic net-
work. As recently as 1994, 89.5% of these plans’ pre-
mium dollars were devoted to direct patient care. By
1995, however, two thirds of the plans, the plans
referred to by Kassirer, were for profit. In that year,
nearly half of all patients in southern California were
enrolled in HMOs, the vast majority of which were
for profit. On average, something less than 75% of
premium dollars were spent on direct patient care.5
Meanwhile, Kaiser’s market share was shrinking with
resultant hospital closure and layoff of hospital per-
sonnel. Dollars were being diverted from patients,
and the physicians and hospitals that provided them
with care. Where are the dollars going? To adminis-
tration and large salaries, to profits, to the often-
overlooked accomplices of the HMOs—the for-
profit Independent physician associations––and con-
spicuously to an advertising campaign that is
encompassing all print and electronic media.
LOSS OF AUTONOMY
Many schemes have undermined the autonomy
of the California physician. From 1978 to 1983,
many insurance companies maintained mandatory
second opinion programs but later abandoned them
because they produced no demonstrable savings.
Preadmission certification, introduced in 1987 under
California Medical Review Initiative control, elabo-
rated an arcane administrative network for precertify-
ing ten major operations, including hysterectomy,
prostatectomy, and cataract extraction. Vascular
surgery was unique in that all arterial procedures
required preadmission certification. This program is
in the process of dying a quiet death. Of course, the
most conspicuous loss of autonomy is the policy of
having gatekeepers, who use guidelines of their own
devising, decide which patients are to be seen by vas-
cular surgeons. Gatekeepers also restrict postopera-
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tive visits so that a cognitive program of patient fol-
low-up care is impossible. Ongoing graft surveillance
for infrainguinal revascularization, for example, is
proscribed.
DEMORALIZATION
Demoralization is endemic to the physicians of
southern California. It seems to be most virulent
among surgical specialists but extends beyond physi-
cians to include hospital employees in general and
nurses. Modern Health Care6 reported that among
general hospital employees, the number of hospitals
that rank morale as their most serious problem
increased from 67% in 1994 to 86% in 1996.
Improving morale is futile when one’s coworkers are
fired to achieve fiscal savings so that capitation rates
can be met at the cost of quality patient care. It is
estimated by the Advisory Board Company7 that the
new standards to be achieved by the year 2000 will
produce a reduction in cost per adjusted discharge
from $5572 to $3781. Full-time employees per
adjusted occupied bed will be reduced from 5.1 to
3.8, and labor costs per net revenue will decrease
from 50% to 35%. These reductions will be achieved
through elimination of hospital employees, nurses in
particular, further reducing quality of care. 
Physicians are demoralized for reasons other
than loss of income. They fear “economic creden-
tialing,” in which they risk loss of privileges if they
spend more money than their peers do in the care of
HMO patients. In our community, we see virtually
no new private practice physicians; most new physi-
cians work for either IPAs or HMOs. In southern
California, because of a fourfold increase in early dis-
ability retirement applications, new claims are fierce-
ly scrutinized. The policies that are now offered have
higher premiums and more restrictive claims poli-
cies. Emigration of southern California physicians to
the east is widely reported, many emigrants lament-
ing the erosion of standards for vascular surgical
care. Decisions about inpatient care are shuttled
along practice guidelines and clinical pathways




It is not as paradoxic as it seems that capitation
rather than limiting utilization stimulates utilization.
The southern California HMOs have established capi-
tation agreements with most hospitals. IPAs, the
patient care arm of HMOs, provide the hospitals with
“hospitalists” and “intensivists,” who not only provide
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care but also decrease resource utilization. These
neospecialists are motivated by the HMOs to keep
charges and costs down, although the HMOs, by cap-
itating physicians, hospitals, and laboratories, have
only second-order motivation to do so. Against this
pattern of practice is the decline in hospital days for the
Medicare population. In 1992, the national average
for hospital days per 100,000 enrollees was 2835. In
California, the average was 1200 days per 100,000,
and for integrated staff-model systems (e.g., Kaiser-
Permanente), it was approximately 900. Seen from
another point of view, inpatient use rate per 100,000
adults was 110 in California, the state with the highest
managed care penetration, and 160 to 170 in
Mississippi and North Dakota, with the lowest HMO
penetration. This decreased utilization and hospital
expenditure by HMOs has affected non-HMO insur-
ance plans. In 1994, the non-HMO payment for coro-
nary artery bypass graft averaged $12,300 in southern
California, $18,000 in northern California, and
$25,000 to $27,000 in the other 46 continental
United States.7 Insurance carriers increasingly are
scrutinizing these geographic differences.
REMUNERATION: THE CASE OF
CAROTID ENDARTERECTOMY
From 1990 to 1997, most but not all vascular
surgeons experienced a reduction in practice
incomes ranging from 20% to 40%. This is in con-
stant (real) dollars (not adjusted for inflation). Were
the figures adjusted for inflation (nominal dollars),
the decreases would be even more staggering. This
same group of surgeons has experienced increases in
workloads of 10% to 50%. Of the six surgical groups
that I polled, all concluded, “We are working hard-
er and getting paid less.” Most vascular surgeons do
HMO/IPA work for modified fee for service, capi-
tation, or both. The changing remuneration pattern
in our practice (based on actual estimate of benefits)
is shown in Table I. In 1971, the amounts charged
for carotid endarterectomy, aneurysm repair, and
femorotibial bypass grafting were collected to with-
in 95%. By 1986, remuneration, although failing to
keep pace with inflation, increased on average by
more than 100% with collections continuing to
exceed 90% of billings. A decade later, the charges
plummeted to levels approaching the 1971 collec-
tions.
The 1996 numbers reflect Medicare-fixed rates.
In 1996, one renegade IPA established payment pro-
files that were so low we terminated our contract. For
this IPA, the payment rates were, in fact, less than
those of Medi-Cal (Medicaid) not only for surgical
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intervention but also for complex consultation. A
comparison of payment for carotid endarterectomy is
shown in Table II. All payment sources––Medicare,
HMO and preferred provider organization (PPO),
and IPA––currently provide a 16% additional remu-
neration for assistants on their modified fee-for-ser-
vice plan, whereas under capitation surgeons are
responsible for providing their own assistants. Also of
note is that many IPAs extract 20% withholding until
the books are closed at the end of the year.
SUGGESTIONS
The growth of HMOs is ineluctable, and this will
undoubtedly further diminish the traditional prac-
tice of vascular surgery. The following are sugges-
tions for dealing with HMOs and IPAs in the future:
1. Upgrade your medical information system and
keep it current. Accurate patient and payment
data are imperative for dealing with insurance
companies.
2. Confer frequently with your colleagues about
practice patterns and payment.
3. Avoid capitation.
4. Include in your negotiations (capitation or fee
for service) payment of fees, inclusion of assis-
tants’ fee, elimination of no withholds, and
specification of all deductions up front.
5. Make sure you are permitted to provide fol-
low-up care to your patients with as little inter-
ference as possible.
6. Establish a “paid-for” graft surveillance pro-
gram if you can.
7. Specify a payment timetable and stick to it.
8. Confirm frequency of review. Perform an
accurate, up-to-date census of enrollees and
compare the utilization data from your med-
ical information system with that of the IPAs.
9. Although most of your income will be from
Medicare “lives,” do not underestimate the
payment, particularly capitation, for commer-
cial lives.
10. If possible, procure an exclusive contract.
11. Even if you have an exclusive contract, deter-
mine whether a third party can contravene
your recommendations.
HMO administrator-entrepreneurs have differ-
ent motivation and incentives than do practicing vas-
cular surgeons. For now they hold most of the cards.
Dealings with them will succeed only with careful
planning, negotiation, and data management.
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TABLE I. Changing remuneration
1996 
Renegade
Procedure 1971 1986 1996 IPA
Carotid thrombo- $1500 ~$2600 $1507 $637.74
endarterectomy
Abdominal aortic $1500 $3800 $2216 $740.75
aneurysm repair
Femorotibial bypass $1400 ~$3500 $2300 $583.13
graft
Complex consultation — — — $72.50
TABLE II. Carotid endarterectomy, 1997
Organization Allowed Payment Secondary Assistant
Medicare $1507 $1205 $302 Yes
HMO/PPO $1485 $1485 — Yes
IPA $1205* $964* — Yes
*Withhold 20% (~$231).
